Revista espanola de medicina nuclear e imagen molecular最新文献

筛选
英文 中文
Evaluation of cardiac angiosarcoma using [18F]FDG PET/CT [18F]FDG PET/CT对心脏血管肉瘤的评价。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-07-01 DOI: 10.1016/j.remnie.2025.500131
B. Hervás-Sanz , N. Ruiz-Roig , L. Rodríguez-Bel , L.M. Gràcia-Sánchez , M. Cortés-Romera , P.C. Notta
{"title":"Evaluation of cardiac angiosarcoma using [18F]FDG PET/CT","authors":"B. Hervás-Sanz , N. Ruiz-Roig , L. Rodríguez-Bel , L.M. Gràcia-Sánchez , M. Cortés-Romera , P.C. Notta","doi":"10.1016/j.remnie.2025.500131","DOIUrl":"10.1016/j.remnie.2025.500131","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 4","pages":"Article 500131"},"PeriodicalIF":0.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144061814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National survey on nuclear imaging in infectious bone pathology: Results and diagnostic recommendations of the Musculoskeletal Pathology Working Group (MSP-WG) 传染性骨病理核成像的全国调查:肌肉骨骼病理工作组(MSP-WG)的结果和诊断建议。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-24 DOI: 10.1016/j.remnie.2025.500165
E. Noriega-Álvarez , A. Moreno-Ballesteros , M. Velasco Nuño , J.M. Cordero García , J.J. Rosales Castillo , U.V. Schmülling , E. López Rodríguez , A. Rigabert Sánchez-Junco , B. Rodríguez Alfonso
{"title":"National survey on nuclear imaging in infectious bone pathology: Results and diagnostic recommendations of the Musculoskeletal Pathology Working Group (MSP-WG)","authors":"E. Noriega-Álvarez ,&nbsp;A. Moreno-Ballesteros ,&nbsp;M. Velasco Nuño ,&nbsp;J.M. Cordero García ,&nbsp;J.J. Rosales Castillo ,&nbsp;U.V. Schmülling ,&nbsp;E. López Rodríguez ,&nbsp;A. Rigabert Sánchez-Junco ,&nbsp;B. Rodríguez Alfonso","doi":"10.1016/j.remnie.2025.500165","DOIUrl":"10.1016/j.remnie.2025.500165","url":null,"abstract":"<div><div>The continued increase in demand for diagnosis and monitoring of infectious bone diseases, along with the introduction of new equipment, radiopharmaceuticals, and techniques for this purpose, has made it necessary to dynamically update the existing protocols and recommendations. Therefore, the MSP-WG conducted a survey for spanish hospitals to complete and develop recommendations in the form of algorithms, in an attempt to combine existing scientific evidence with the reality of national clinical practice.</div></div>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":"44 5","pages":"Article 500165"},"PeriodicalIF":0.0,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144510165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of the performance of 18F-PSMA-1007 PET/CT and 68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence. 18F-PSMA-1007 PET/CT与68Ga-PSMA-11 PET/CT在前列腺癌生化复发患者中的比较评价
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-21 DOI: 10.1016/j.remnie.2025.500178
G Inal, C Soydal, B Demir, M Araz, Y Urun, S Baltacı, E Suer, N O Kucuk
{"title":"Comparative evaluation of the performance of <sup>18</sup>F-PSMA-1007 PET/CT and <sup>68</sup>Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence.","authors":"G Inal, C Soydal, B Demir, M Araz, Y Urun, S Baltacı, E Suer, N O Kucuk","doi":"10.1016/j.remnie.2025.500178","DOIUrl":"10.1016/j.remnie.2025.500178","url":null,"abstract":"<p><strong>Aim: </strong>In this study, we aimed to evaluate the diagnostic performance of <sup>18</sup>F-PSMA-1007 PET/CT compared to <sup>68</sup>Ga-PSMA-11 PET/CT, which is more commonly used in routine practice, for detecting prostate cancer recurrence in prostate cancer patients with biochemical recurrence.</p><p><strong>Materials and methods: </strong>Forty-one prostate cancer patients with biochemical recurrence were prospectively included in the study. Additionally, images from 46 patients in our institution's database, who had undergone <sup>68</sup>Ga-PSMA-11 PET/CT imaging for biochemical recurrence, were retrospectively re-evaluated to compare the detection rates with those of <sup>18</sup>F-PSMA-1007 PET/CT. SUVmax, total tumor PSMA, PSMA total tumor volume were calculated for local recurrence, lymph node metastasis, and organ metastasis. The diagnostic performances of the two imaging methods were then compared.</p><p><strong>Results: </strong>The mean age, Gleason scores, ISUP scores, serum PSA levels at diagnosis and at the time of imaging, and PSA doubling times were similar across the <sup>18</sup>F-PSMA-1007 and <sup>68</sup>Ga-PSMA-11 groups. Pathological uptake was observed in the prostatic bed in 16 patients (39.0%), lymph nodes in 22 patients (46.3%), and bones in 11 patients (26.8%) with <sup>18</sup>F-PSMA-1007 PET/CT. <sup>18</sup>F-PSMA-1007 PET/CT showed statistically significant superiority over <sup>68</sup>Ga-PSMA-11 PET/CT in detecting lymph node metastases (41.6% vs. 25.4%; P=.028). There was no significant difference between the two imaging protocols in the detection rates of local recurrence (P=.067) and bone metastasis (P=.580).</p><p><strong>Conclusion: </strong>Although the study included a small sample size, the results revealed that <sup>18</sup>F-PSMA-1007 PET/CT had a higher detection rate than <sup>68</sup>Ga-PSMA-11 PET/CT in patients with biochemically recurrent prostate carcinoma, particularly for lymph node metastases.</p>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500178"},"PeriodicalIF":0.0,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144478397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
May it be a new parameter of 18F-FDG PET/CT for differentiating between benign and malignant adrenal lesions: "Adrenal Densitometabolic Index (ADMI)". “肾上腺密度代谢指数(ADMI)”可能成为18F-FDG PET/CT鉴别肾上腺良恶性病变的新参数。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-20 DOI: 10.1016/j.remnie.2025.500185
E Ciftci, T Y Erdil, B Karaşah Erkek, B Akovali
{"title":"May it be a new parameter of 18F-FDG PET/CT for differentiating between benign and malignant adrenal lesions: \"Adrenal Densitometabolic Index (ADMI)\".","authors":"E Ciftci, T Y Erdil, B Karaşah Erkek, B Akovali","doi":"10.1016/j.remnie.2025.500185","DOIUrl":"10.1016/j.remnie.2025.500185","url":null,"abstract":"<p><strong>Objective: </strong>This study evaluates the diagnostic importance of a new parameter consisting of the densitometric and metabolic properties of the lesion measured by 18F-FDG PET/CT in differentiating between benign and malignant adrenal lesions in cancer patients.</p><p><strong>Material and methods: </strong>We evaluated PET/CT parameters of adrenal lesions of patients between 2017 and 2019. A new parameter, \"Adrenal Dansitometabolic index (ADMI),\" was investigated. Additionally, SUVmax, tumor-to-liver ratio (T/LR), Hounsfield Units (HU), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of adrenal lesions were analyzed. Logistic regression analyses were conducted to identify the most predictive parameter for malignant lesions.</p><p><strong>Results: </strong>Two hundred and four adrenal lesions underwent PET/CT for tumor evaluation. Based on ROC analysis, ADMI > 9.5, a SUVmax > 4.15, a T/L SUVmax ratio > 1.7, an attenuation value > 21.75 HU, a TLG > 14.61 and a MTV > 4.5 were chosen as the optimal cut-off values for differentiating malignant from benign lesions. ADMI, SUVmax, and T/L ratio demonstrated similarly high diagnostic performance (AUC values: 0.993, 0.992 and 0.988 (P = .000), respectively). ADMI exhibited the highest sensitivity and negative predictive value. A multivariate logistic regression analysis revealed that both ADMI and T/L ratio serve as independent prognostic factors for malignancy (P = .001 and P = .003, respectively).</p><p><strong>Conclusion: </strong>ADMI, effectively distinguishes benign from malignant. This technique may facilitate investigations of the adrenal lesions to clinical outcomes but needs further large series studies.</p>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500185"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pretreatment 18F-FDG PET/CT in predicting the survival of patients with hepatic neuroendocrine tumors. 预处理18F-FDG PET/CT预测肝神经内分泌肿瘤患者的生存。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-20 DOI: 10.1016/j.remnie.2025.500198
Y Zhang, G Liu, L Zhong, B Li, Y Zhang
{"title":"Pretreatment <sup>18</sup>F-FDG PET/CT in predicting the survival of patients with hepatic neuroendocrine tumors.","authors":"Y Zhang, G Liu, L Zhong, B Li, Y Zhang","doi":"10.1016/j.remnie.2025.500198","DOIUrl":"10.1016/j.remnie.2025.500198","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the prognostic value of pretreatment 2-[<sup>18</sup>F]-fluoro-2-deoxy-d-glucose (<sup>18</sup>F-FDG) positron emission tomography/computed tomography (PET/CT) in patients with hepatic neuroendocrine tumors (HNET).</p><p><strong>Methods: </strong>In total, 41 patients were included in this study. PET-derived metabolic parameters, including maximum and mean standardized uptake values (SUV<sub>max</sub> and SUV<sub>mean</sub>, respectively), metabolic tumor volume (MTV), and total lesion glycolysis (TLG), of the tumors were measured. Meanwhile, clinical data, including tumor pathological findings such as the Ki-67 index were also assessed. Progression-free survival (PFS) and overall survival (OS) were evaluated. Univariate and multivariate analyses were performed to predict the prognostic value of clinical variables and PET-derived metabolic parameters in HNET patients. Correlation between PET-derived metabolic parameters and Ki-67 was estimated.</p><p><strong>Results: </strong>Univariate analyses revealed that among PET-derived metabolic parameters, SUV<sub>max</sub>, SUV<sub>mean</sub>, and TLG were significant prognostic factors for OS (P < .05). Among clinical variables, the Ki-67 index and radical surgical resection were significant factors for both PFS and OS (P < .05). In multivariate analyses, only Ki-67 index was an independent prognostic factor for both PFS and OS (P < .05). Ki-67 index presented correlates with SUV<sub>max</sub> and SUV<sub>mean</sub> (R = 0.566, P < .001, R = 0.493, P = .001, respectively).</p><p><strong>Conclusions: </strong>In patients with HNET, the Ki-67 index was an independent prognostic factor for both PFS and OS, while SUV<sub>max</sub>, SUV<sub>mean</sub>, and TLG measured on pretreatment <sup>18</sup>F-FDG PET/CT scans were prognostic factors for predicting OS. Ki-67 index also presented correlates with SUV<sub>max</sub> and SUV<sub>mean</sub>. <sup>18</sup>F-FDG-PET may be useful as quantitative predicting prognostic imaging biomarkers, especially in poorly differentiated HNET.</p>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500198"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Massive subcutaneous emphysema and complete resorption images detected on [18F]-FDG PET/CT. [18F]-FDG PET/CT检测大量皮下肺气肿和完全吸收图像。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-20 DOI: 10.1016/j.remnie.2025.500180
M T Tatoğlu, H Uslu
{"title":"Massive subcutaneous emphysema and complete resorption images detected on [<sup>18</sup>F]-FDG PET/CT.","authors":"M T Tatoğlu, H Uslu","doi":"10.1016/j.remnie.2025.500180","DOIUrl":"10.1016/j.remnie.2025.500180","url":null,"abstract":"<p><p>Subcutaneous emphysema may occur iatrogenically, spontaneously, or post-traumatically as a result of free air passage under the skin from the respiratory tract or gastrointestinal tract. In this case, we present the typical appearance of a case of massive subcutaneous emphysema observed on [18F]-FDG PET/CT for metabolic characterization due to a massive lesion in the lung and the images of complete resorption after seven months.</p>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500180"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal bone tuberculosis with adrenal involvement mimicking malignant tumors with multiple metastases on PET/CT. 累及肾上腺的多灶性骨结核在PET/CT上表现为恶性肿瘤伴多发转移。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-20 DOI: 10.1016/j.remnie.2025.500141
W Zhang, Y Xing, A Kuang, Y Li
{"title":"Multifocal bone tuberculosis with adrenal involvement mimicking malignant tumors with multiple metastases on PET/CT.","authors":"W Zhang, Y Xing, A Kuang, Y Li","doi":"10.1016/j.remnie.2025.500141","DOIUrl":"10.1016/j.remnie.2025.500141","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500141"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
68Ga-FAPI and 18F-FDG PET/CT: Complementary imaging modalities for detecting unusual metastasis in a patient with osteosarcoma. 68Ga-FAPI和18F-FDG PET/CT:检测骨肉瘤患者异常转移的互补成像方式
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-20 DOI: 10.1016/j.remnie.2025.500137
G A Divband, E Askari, H R Amini, A R Noferesti, P Sahafi
{"title":"<sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG PET/CT: Complementary imaging modalities for detecting unusual metastasis in a patient with osteosarcoma.","authors":"G A Divband, E Askari, H R Amini, A R Noferesti, P Sahafi","doi":"10.1016/j.remnie.2025.500137","DOIUrl":"10.1016/j.remnie.2025.500137","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500137"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond the standard: Enhancing prostate bed and regional lymph node detection in prostate cancer patients with early and delayed imaging in [68 Ga]Ga-PSMA-11 PET/CT. 超越标准:通过[68 Ga]Ga- psma -11 PET/CT早期和延迟成像增强前列腺癌患者的前列腺床和区域淋巴结检测。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-20 DOI: 10.1016/j.remnie.2025.500184
A Aghaee, Z Bakhshi, V Roshanravan, N Norouzbeigi, H Dadgar, E Askari, K Aryana, S Shafiei, S Soltani, S Sadeghpour
{"title":"Beyond the standard: Enhancing prostate bed and regional lymph node detection in prostate cancer patients with early and delayed imaging in [68 Ga]Ga-PSMA-11 PET/CT.","authors":"A Aghaee, Z Bakhshi, V Roshanravan, N Norouzbeigi, H Dadgar, E Askari, K Aryana, S Shafiei, S Soltani, S Sadeghpour","doi":"10.1016/j.remnie.2025.500184","DOIUrl":"10.1016/j.remnie.2025.500184","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to evaluate the diagnostic value of early static and delayed imaging in conjunction with standard 68Ga-PSMA-11 PET/CT scans to detect prostate malignant lesions in prostate cancer patients.</p><p><strong>Methods: </strong>One hundred and thirty-eight prostate cancer patients underwent routine [68 Ga]Ga-PSMA-11 PET/CT imaging, 4-minute static acquisition post-injection, and delayed imaging 3 h post-injection. The imaging results were analysed for lesion count, type, localisation, and maximum standardised uptake values.</p><p><strong>Results: </strong>57.97% exhibited positive findings for pathologic prostatic lesions in the standard PET scans (SUV<sub>max</sub>: 10.24). In contrast, early PET imaging detected lesions in 58.01% of patients (SUV<sub>max</sub> of 5.86), while delayed scans revealed lesions suggestive of malignancy in 55.45% of patients (SUV<sub>max</sub> of 12.79). The analysis demonstrated a statistically significant difference in SUV<sub>max</sub> values across the time points (P < .001). Pathologic lymph nodes on images 60 min p.i. were revealed by an SUV max 60 min p.i.: 15.78; this number for the first 4 min and after 3 h were 7.36, 19.19, respectively. Metastatic bone lesions on WB were found in 38 patients, more than the ESI (n = 37) and DI (n = 24). In comparison, urinary bladder activity assessment was detectable with the WB imaging SUV<sub>max</sub> 60 min 11.07. Even though the SUV max for ESI and DI were 6.95 and 31.97, respectively. In the statistical analysis, pathologic radiotracer uptake in tumour lesions was statistically higher in ESI and WB than in urinary bladder activity.</p><p><strong>Conclusions: </strong>The findings indicate that neither early [68 Ga]Ga-PSMA-11 PET/CT nor delayed imaging significantly enhanced the overall detection rate of malignant lesions in prostate cancer patients.​ However, the early 4-minute post-injection acquisition of PET images proved beneficial for distinguishing local bladder invasion more effectively.</p>","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500184"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidental detection of bone metastases from gastric cancer on [99mTc]Tc-DTPA renal dynamic scintigraphy. [99mTc]Tc-DTPA肾动态显像偶然发现胃癌骨转移。
Revista espanola de medicina nuclear e imagen molecular Pub Date : 2025-06-20 DOI: 10.1016/j.remnie.2025.500196
C Nong, Y Xing, L Jiang, Z Zhao
{"title":"Incidental detection of bone metastases from gastric cancer on [99mTc]Tc-DTPA renal dynamic scintigraphy.","authors":"C Nong, Y Xing, L Jiang, Z Zhao","doi":"10.1016/j.remnie.2025.500196","DOIUrl":"10.1016/j.remnie.2025.500196","url":null,"abstract":"","PeriodicalId":94197,"journal":{"name":"Revista espanola de medicina nuclear e imagen molecular","volume":" ","pages":"500196"},"PeriodicalIF":0.0,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144370013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信